CTOs on the Move

APPLIED OPTRONICS

www.applied-optronics.com

 
APPLIED OPTRONICS is a South Plainfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

United Hospital Supply Corp

United Hospital Supply Corp is a Burlington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sedecal USA

Sedecal USA is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Urotronic

Urotronic Inc. is an early stage medical device company developing drug/device combination products. Our mission is to develop revolutionary technologies that will transform the urology market through better patient outcomes that are uniquely positioned for today`s healthcare environment.

Powered by MRP

Powered by MRP wants to radically decrease healthcare cost with technology first solutions. Our commitment is to build the first digitally enabled end- to-end marketplace for Medical Aesthetic Professional. At Powered by MRP we focus on providing medical devices, resources, training, education and support to our customers to empower them to deliver top service to their clients. We are committed to a culture of collaboration where every voice is heard and understood. We believe in embracing diversity and that it brings better insight, solutions, and serves as the most intentional way to better our company. This supports our strategy, partnerships and collaboration to achieve being the most trusted Aesthetic Marketplace throughout the world.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.